Tianjin Minxiang Pharmaceutical Chemical

Tianjin Minxiang Biomedical is a specialized pharmaceutical company focused on the research, development, and commercial production of high-end Active Pharmaceutical Ingredients (APIs) and chemical intermediates. The company is a significant global supplier of antiviral treatments, particularly for HIV and Hepatitis B, and is a major producer of adamantane-series derivatives used in neurology. Their core product line includes memantine hydrochloride for Alzheimer's disease and various intermediates for tenofovir and entecavir. Operating from its headquarters in Tianjin and a large-scale production base in Ningxia, the company adheres to international GMP standards. Tianjin Minxiang also provides comprehensive CDMO services, supporting global pharmaceutical partners with process development and custom synthesis.